DEFA14A8-K ·Filed Apr 23, 2026
Actionable Insight ▲ Bullish
Monitor the shareholder vote and regulatory approvals for deal closure; watch for updates on the Vibativ milestone payment.
Final — all horizons settled through T+60d
CPIX ▲ +87.18% at T+60d
LONG call ✓ call won +87.18% · α vs SPY +82.16% · entry $3.90 → $7.30
T+1d
+4.10%
call +4.10% · α +3.32%
$4.06
settled 6mo ago
T+5d
+7.95%
call +7.95% · α +6.47%
$4.21
settled 6mo ago
T+20d
+41.79%
call +41.79% · α +37.16%
$5.53
settled 5mo ago
T+60d
+87.18%
call +87.18% · α +82.16%
$7.30
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cumberland Pharmaceuticals is selling its commercial pharmaceutical products and related assets to Apotex for $100 million in cash. The transaction includes a $4 million termination fee and a potential future milestone payment tied to Vibativ sales. Cumberland will retain its pipeline assets.
Key Financial Metrics
Deal Value
$100.0M
Deal Type
acquisition
Key Facts
- Cumberland Pharmaceuticals (CPIX) is selling its commercial product line and related assets to Apotex for $100 million in cash.
- The transaction includes a $4 million termination fee payable by Cumberland if the deal fails under certain conditions.
- A potential future milestone payment is tied to the performance of the Vibativ product.
- Cumberland will retain its pipeline assets and focus on developing orphan drug candidates.
- The deal requires shareholder approval and is subject to customary closing conditions.
Financial Impact
The deal is valued at $100 million in cash, with a potential future milestone payment tied to Vibativ sales.
revenuedilutiondebt
Risk Factors
- Failure to obtain shareholder approval
- Regulatory hurdles
- Potential litigation
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (CPIX) — Batch item 1 | 0001104659-26-047338 |
| Document: tm2611622d2_ex10-1.htm | 0001104659-26-047335 |
| Document: tm2611622d2_defa14a.htm | 0001104659-26-047338 |
| Document: tm2611622d2_ex99-1.htm | 0001104659-26-047338 |
| Document: 0001104659-26-047338-index-headers.html | 0001104659-26-047338 |
| Document: 0001104659-26-047338-index.html | 0001104659-26-047338 |
| Document: 0001104659-26-047338.txt | 0001104659-26-047338 |
| 8-K Filing (CPIX) — Batch item 8 | 0001104659-26-047335 |
6 reports for CPIX
100% Hit rate @ T+1 Went positive at some point 3 of 3 best @ T+20▲ +19.11%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 8-K | $8.46 | awaiting T+1 | — | $4.36 (−48.46%) |
Aug 28, 2026 8w ago | 8-K | $6.69 $6.56 | ▲ +1.94% | ▲ +1.26% | $4.36 (+34.82%) |
Jul 13, 2026 15w ago | Press Release | $6.54 $6.99 | ▲ +6.80% | ▲ +6.45% | $4.36 (−33.33%) |
May 26, 2026 21w ago | DEFM14A | $5.77 $5.86 | ▲ +1.56% | ▲ +1.55% | $4.36 (−24.43%) |
Apr 23, 2026 26w ago | DEFA14A / 8-K | $3.90 $4.06 | ▲ +4.10% | ▲ +3.32% | $4.36 (+11.80%) |
Mar 9, 2026 32w ago | DEFA14A | $3.16 $3.08 | ▼ −2.53% | ▼ −2.43% | $4.36 (+37.98%) |
Showing 6 of 6
US Market Status
Market Closed — Opens Tue (17h 30m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers